Evidence map›Paper›PMID 39548906›Full record

ArticleEuropean journal of immunology2025

The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice.

Jasmin Mann, Solveig Runge, Christoph Schell, Katja Gräwe, Gudrun Thoulass, Jessica Lao, Sandra Ammann, Sarah Grün, Christoph König, Sarah A Berger and 4 more

Abstract read
In one paragraph

Article in European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jasmin MannInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Solveig RungeFaculty of Biology, University of Freiburg, Freiburg, Germany.
Christoph SchellInstitute for Surgical Pathology, Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Katja GräweInstitute for Surgical Pathology, Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Gudrun ThoulassInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Jessica LaoInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sandra AmmannInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sarah GrünInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Christoph KönigInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Sarah A BergerInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Benedikt HildDepartment of Gastroenterology, Hepatology and Transplantation Medicine, Medical Faculty University of Duisburg-Essen, Essen, Germany.
Peter AicheleInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Stephan P RosshartDepartment of Medicine II, Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-6989-8686
Stephan EhlInstitute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center- University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-9265-2721

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) 450392965DFG Emmy Noether-Program RO 6247/1-1 446316360DFG SFB1160 IMPATH 256073931TRR 359 PILOT 491676693
6 · The paper itself

Abstract

Primary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome caused by inborn errors of cytotoxicity. Patients with biallelic PRF1 null mutations (encoding perforin) usually develop excessive immune cell activation, hypercytokinemia, and life-threatening immunopathology in the first 6 months of life, often without an apparent infectious trigger. In contrast, perforin-deficient (PKO) mice only develop HLH after systemic infection with lymphocytic choriomeningitis virus (LCMV). We hypothesized that restricted microbe-immune cell interactions due to specific pathogen-free (SPF) housing might explain the need for this specific viral trigger in PKO mice. To investigate the influence of a "wild" microbiome in PKO mice, we fostered PKO newborns with Wildling microbiota ('PKO-Wildlings') and monitored them for signs of HLH. PKO-Wildlings survived long-term without spontaneous disease. Also, systemic infection with vaccinia virus did not reach the threshold of immune activation required to trigger HLH in PKO-Wildlings. Interestingly, after infection with LCMV, PKO-Wildlings developed an altered HLH pattern. This included lower IFN-γ serum levels along with improved IFN-γ-driven anemia, but more elevated levels of IL-17 and increased liver inflammation compared with PKO-SPF mice. Thus, wild microbiota alone is not sufficient to trigger HLH in PKO mice, but host-microbe interactions shape inflammatory cytokine patterns, thereby influencing manifestations of HLH immunopathology.

Indexed as

Lymphohistiocytosis, HemophagocyticMicrobiotaPerforinAnimalsDisease Models, AnimalLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred C57BLMice, KnockoutPerforinhemophagocytic lymphohistiocytosismicrobiomeperforin‐deficiencyWildling

Identifiers

PMID39548906
PMCPMC11739664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.